Targeting CK2 for cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting CK2 for cancer therapy

Published:2005-11 Issue:10 Volume:16 Page:1037-1043
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:Anti-Cancer Drugs

Author:

Ahmad Kashif A.,Wang Guixia,Slaton Joel,Unger Gretchen,Ahmed Khalil

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference49 articles.

1. Protein Kinase CK2 as Regulator of Cell Survival: Implications for Cancer Therapy

2. Significance of protein kinase CK2 nuclear signaling in neoplasia

3. Joining the cell survival squad: an emerging role for protein kinase CK2

4. Protein kinase CK2: structure, regulation and role in cellular decisions of life and death

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of cancer progression by CK2: an emerging therapeutic target;Medical Oncology;2024-03-25

2. Synthesis and Anticancer Activity of Novel Dual Inhibitors of Human Protein Kinases CK2 and PIM-1;Pharmaceutics;2023-07-20

3. Roles of Metastasis Suppressor Gene, OGR1 and Casein Kinase 2$$\alpha$$ Intronless Gene, CSNK2A3 in Megakaryocytic Differentiation;Healthcare Research and Related Technologies;2023

4. Antitumor activity of the protein kinase inhibitor 1-(β-D-2′-deoxyribofuranosyl)-4,5,6,7-tetrabromo- 1H-benzimidazole in breast cancer cell lines;BMC Cancer;2022-10-15

5. Protein kinase CK2 – diverse roles in cancer cell biology and therapeutic promise;Molecular and Cellular Biochemistry;2022-09-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3